Characterization of agonist stimulation of cAMP-dependent protein kinase and G protein-coupled receptor kinase phosphorylation of the beta2-adrenergic receptor using phosphoserine-specific antibodies.

Agonist-stimulated desensitization of the beta2-adrenergic receptor (beta2AR) is caused by both a potent cAMP-dependent protein kinase (PKA)-mediated phosphorylation and a less potent, occupancy-dependent, G protein-coupled receptor kinase (GRK)-mediated phosphorylation that leads to beta-arrestin binding and internalization. In this study the kinetics of phosphorylation of the third intracellular loop PKA site Ser262 and the putative C-tail GRK sites Ser355, Ser356 of the human beta2AR overexpressed in human embryonic kidney (HEK) 293 cells were characterized using phosphoserine-specific antibodies. Specificity of the antibodies was shown by their lack of reactivity with mutant beta2ARs lacking the respective sites. In addition, overexpression of GRK2 and GRK5 increased basal levels of phosphorylation of the GRK sites Ser355, Ser356 in both COS-7 and HEK 293 cells. Epinephrine, prostaglandin E1, and forskolin at maximum concentrations stimulated phosphorylation of the beta2AR PKA site (Ser262) by 4-fold, whereas PMA stimulated it by 2-fold. Epinephrine stimulated PKA site phosphorylation with an EC50 of 20 to 40 pM. In contrast, epinephrine stimulated GRK site phosphorylation (Ser355,Ser356) with an EC50 of 200 nM (1-min treatments), which is more than 4000-fold higher relative to PKA site phosphorylation, consistent with an occupancy-driven process. After 10 to 30 min, the EC50 for epinephrine stimulation of GRK site phosphorylation was reduced to 10 to 20 nM but was still approximately 200-fold greater than for the PKA site. The EC50 for internalization correlated with GRK site phosphorylation and showed a similar shift with time of epinephrine stimulation. The kinetics of epinephrine-stimulated GRK site phosphorylation were not altered in a mutant of the beta2AR lacking the PKA consensus sites. The initial levels (2 min) of a range of agonist-stimulated GRK site phosphorylations were correlated with their efficacy for activation of adenylyl cyclase, namely epinephrine > or = formoterol = fenoterol > terbutaline = zinterol = albuterol > salmeterol > dobutamine > or = ephedrine. However, after 20 to 30 min of treatment, agonists with intermediate strengths, such as albuterol and salmeterol, stimulate GRK site phosphorylations that are approximately equal to that produced by epinephrine, and the correlation breaks down. The GRK and PKA site antibodies were also effective in detecting phosphorylation of the endogenous beta2AR expressed in A431 human epidermoid carcinoma cells. To summarize, our results show a remarkable amplification of PKA site phosphorylation relative to the putative GRK site phosphorylation, heterologous stimulation of the PKA site phosphorylation, no dependence of GRK site phosphorylation on PKA sites, and a reasonable correlation of initial levels of GRK site phosphorylation with the strength of a range of agonists.

[1]  J. Benovic,et al.  Pharmacological inhibition of protein kinases in intact cells: antagonism of beta adrenergic receptor ligand binding by H-89 reveals limitations of usefulness. , 1999, The Journal of pharmacology and experimental therapeutics.

[2]  I. Hall,et al.  Pharmacological characterization of CGP 12177 at the human β2‐adrenoceptor , 2002 .

[3]  B. J. Knoll,et al.  Localization of the sites mediating desensitization of the beta(2)-adrenergic receptor by the GRK pathway. , 2000, Molecular pharmacology.

[4]  M. Johnson,et al.  Stable activation and desensitization of beta 2-adrenergic receptor stimulation of adenylyl cyclase by salmeterol: evidence for quasi-irreversible binding to an exosite. , 1996, Molecular pharmacology.

[5]  B. Rana.  New insights into G-protein-coupled receptor signaling from the melanocortin receptor system. , 2003, Molecular pharmacology.

[6]  L. Birnbaumer,et al.  Differential expression of the beta-adrenergic receptor modifies agonist stimulation of adenylyl cyclase: a quantitative evaluation. , 1994, Molecular pharmacology.

[7]  M. Kunkel,et al.  Activation of cAMP-dependent protein kinase is required for heterologous desensitization of adenylyl cyclase in S49 wild-type lymphoma cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[8]  M. Caron,et al.  Synthetic peptides of the hamster beta 2-adrenoceptor as substrates and inhibitors of the beta-adrenoceptor kinase. , 1990, British journal of clinical pharmacology.

[9]  R. Lefkowitz,et al.  The G-protein-coupled receptor phosphatase: a protein phosphatase type 2A with a distinct subcellular distribution and substrate specificity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A M Krumins,et al.  The stability of the agonist beta2-adrenergic receptor-Gs complex: evidence for agonist-specific states. , 1997, Molecular pharmacology.

[11]  J. Benovic,et al.  The role of receptor kinases and arrestins in G protein-coupled receptor regulation. , 1998, Annual review of pharmacology and toxicology.

[12]  M. Oppermann,et al.  Analysis of Ligand-stimulated CC Chemokine Receptor 5 (CCR5) Phosphorylation in Intact Cells Using Phosphosite-specific Antibodies* , 2003, The Journal of Biological Chemistry.

[13]  R. Clark,et al.  Kinetic analysis of agonist-induced down-regulation of the beta(2)-adrenergic receptor in BEAS-2B cells reveals high- and low-affinity components. , 2000, Molecular pharmacology.

[14]  J. Friedman,et al.  Beta(2)-adrenergic receptor lacking the cyclic AMP-dependent protein kinase consensus sites fully activates extracellular signal-regulated kinase 1/2 in human embryonic kidney 293 cells: lack of evidence for G(s)/G(i) switching. , 2002, Molecular pharmacology.

[15]  J. Benovic,et al.  Expression, purification, and characterization of the G protein-coupled receptor kinase GRK5. , 1994, The Journal of biological chemistry.

[16]  B. J. Knoll,et al.  Salmeterol‐induced desensitization, internalization and phosphorylation of the human β2‐adrenoceptor , 1998, British journal of pharmacology.

[17]  B. Kobilka,et al.  Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changes. , 1995, The Journal of biological chemistry.

[18]  R. Clark,et al.  cAMP-dependent protein kinase and protein kinase C consensus site mutations of the beta-adrenergic receptor. Effect on desensitization and stimulation of adenylylcyclase. , 1994, The Journal of biological chemistry.

[19]  T. Rich,et al.  Probing the roles of protein kinases in g-protein-coupled receptor desensitization. , 2003, Molecular pharmacology.

[20]  C. Strader,et al.  Identification of a specific domain in the beta-adrenergic receptor required for phorbol ester-induced inhibition of catecholamine-stimulated adenylyl cyclase. , 1990, Molecular pharmacology.

[21]  R. Clark,et al.  Adenylate cyclase coupling proteins are not essential for agonist-specific desensitization of lymphoma cells. , 1981, The Journal of biological chemistry.

[22]  P. Leff,et al.  Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus. , 1998, Molecular pharmacology.

[23]  G. Rousseau,et al.  The palmitoylation state of the β2‐adrenergic receptor regulates the synergistic action of cyclic AMP‐dependent protein kinase and β‐adrenergic receptor kinase involved in its phosphorylation and desensitization , 2001, Journal of neurochemistry.

[24]  J. Furness,et al.  Opioid Agonists Have Different Efficacy Profiles for G Protein Activation, Rapid Desensitization, and Endocytosis of Mu-opioid Receptors* , 2003, Journal of Biological Chemistry.

[25]  Stephen S. G. Ferguson,et al.  Synergistic Regulation of β2-Adrenergic Receptor Sequestration: Intracellular Complement of β-Adrenergic Receptor Kinase and β-Arrestin Determine Kinetics of Internalization , 1997 .

[26]  B. J. Knoll,et al.  Partial agonists and G protein-coupled receptor desensitization. , 1999, Trends in pharmacological sciences.

[27]  T. Kenakin,et al.  G Protein-Coupled Receptor Allosterism and Complexing , 2002, Pharmacological Reviews.

[28]  M. Bouvier,et al.  Phorbol‐ester‐induced phosphorylation of the β2‐adrenergic receptor decreases its coupling to Gs , 1991, FEBS letters.

[29]  E. Shumay,et al.  Akt Mediates Sequestration of the β2-Adrenergic Receptor in Response to Insulin* , 2002, The Journal of Biological Chemistry.

[30]  A. Seibold,et al.  β2-Adrenergic Receptor Desensitization, Internalization, and Phosphorylation in Response to Full and Partial Agonists* , 1997, The Journal of Biological Chemistry.

[31]  T. Kohout,et al.  Regulation of G protein-coupled receptor kinases and arrestins during receptor desensitization. , 2003, Molecular pharmacology.

[32]  R. Bond,et al.  The elusive nature of intrinsic efficacy. , 1998, Trends in pharmacological sciences.

[33]  E. Shumay,et al.  c-Src Tyrosine Kinase Binds the β2-Adrenergic Receptor via Phospho-Tyr-350, Phosphorylates G-protein-linked Receptor Kinase 2, and Mediates Agonist-induced Receptor Desensitization* , 2001, The Journal of Biological Chemistry.

[34]  C. Strader,et al.  Identification of a specific site required for rapid heterologous desensitization of the beta-adrenergic receptor by cAMP-dependent protein kinase. , 1989, Molecular pharmacology.

[35]  M. Caron,et al.  A small region of the beta-adrenergic receptor is selectively involved in its rapid regulation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[36]  A. Milam,et al.  Rhodopsin Phosphorylation and Dephosphorylation in Vivo(*) , 1995, The Journal of Biological Chemistry.

[37]  S. Shenolikar,et al.  Cell‐free heterologous desensitization of adenylyl cyclase in S49 lymphoma cell membranes mediated by cAMP‐dependent protein kinase , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  B. Mouillac,et al.  Palmitoylated Cysteine 341 Modulates Phosphorylation of the β2-Adrenergic Receptor by the cAMP-dependent Protein Kinase* , 1996, The Journal of Biological Chemistry.

[39]  R. Clark,et al.  β2-Adrenergic Receptor Lacking the Cyclic AMP-Dependent Protein Kinase Consensus Sites Fully Activates Extracellular Signal-Regulated Kinase 1/2 in Human Embryonic Kidney 293 Cells: Lack of Evidence for Gs/Gi Switching. , 2002 .

[40]  J. Friedman,et al.  Desensitization of β2-Adrenergic Receptors with Mutations of the Proposed G Protein-coupled Receptor Kinase Phosphorylation Sites* , 1998, The Journal of Biological Chemistry.